Phase II trial of afatinib in patients with advanced/metastatic urothelial carcinoma (UC) with genetic alterations in ERBB receptors 1-3 who failed on platinum-based chemotherapy (CT)
Font Pous, Albert, Puente, Javier, Castellano, Daniel E., Real, Francisco X., Climent, Miguel A., Gonzalez del Alba, Aranzazu Aranzazu, Oudard, Stephane, Vazquez Mazon, Federico Jose, Morales Barrera, Rafael, Virizuela, Juan Virizuela, Sala, Nuria, Pérez-Valderrama, Begoña, Garcia del Muro, Xavier, Fernandez, Pedro L., Jares, Pedro, Aldecoa, Iban, Gibson, Neil, Serra, Josep, Rodrigo Imedio, Esteban, Mellado, Begona
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article